Citadel Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $203K | Buy |
+14,500
| New | +$195K | ﹤0.01% | 11396 |
|
|
2025
Q2 | – | Sell |
-3,500
| Closed | -$50.2K | – | 12513 |
|
|
2025
Q1 | $50.2K | Sell |
3,500
-2,000
| -36% | -$31.2K | ﹤0.01% | 12312 |
|
|
2024
Q4 | $87.6K | Buy |
5,500
+100
| +2% | +$1.98K | ﹤0.01% | 11663 |
|
|
2024
Q3 | $130K | Buy |
5,400
+4,600
| +575% | +$105K | ﹤0.01% | 10762 |
|
|
2024
Q2 | $15.9K | Sell |
800
-3,100
| -79% | -$60.4K | ﹤0.01% | 12805 |
|
|
2024
Q1 | $77.6K | Sell |
3,900
-3,800
| -49% | -$73.5K | ﹤0.01% | 11695 |
|
|
2023
Q4 | $173K | Buy |
7,700
+5,800
| +305% | +$120K | ﹤0.01% | 10172 |
|
|
2023
Q3 | $38.4K | Buy |
1,900
+600
| +46% | +$13.6K | ﹤0.01% | 12043 |
|
|
2023
Q2 | $33.2K | Sell |
1,300
-2,000
| -61% | -$52.7K | ﹤0.01% | 12249 |
|
|
2023
Q1 | $98.1K | Buy |
3,300
+800
| +32% | +$23.2K | ﹤0.01% | 11295 |
|
|
2022
Q4 | $67.7K | Buy |
+2,500
| New | +$61.1K | ﹤0.01% | 11752 |
|
|
2022
Q3 | – | Sell |
-8,400
| Closed | -$230K | – | 12591 |
|
|
2022
Q2 | $230K | Sell |
8,400
-7,100
| -46% | -$204K | ﹤0.01% | 10403 |
|
|
2022
Q1 | $519K | Sell |
15,500
-17,800
| -53% | -$573K | ﹤0.01% | 9298 |
|
|
2021
Q4 | $1.16M | Buy |
33,300
+25,500
| +327% | +$824K | ﹤0.01% | 7591 |
|
|
2021
Q3 | $243K | Sell |
7,800
-100
| -1% | -$3.39K | ﹤0.01% | 11536 |
|
|
2021
Q2 | $287K | Buy |
+7,900
| New | +$327K | ﹤0.01% | 11376 |
|
|
2021
Q1 | – | Sell |
-6,900
| Closed | -$317K | – | 13146 |
|
|
2020
Q4 | $317K | Sell |
6,900
-700
| -9% | -$29.1K | ﹤0.01% | 8974 |
|
|
2020
Q3 | $252K | Sell |
7,600
-3,500
| -32% | -$112K | ﹤0.01% | 8424 |
|
|
2020
Q2 | $326K | Buy |
11,100
+700
| +7% | +$20.3K | ﹤0.01% | 7773 |
|
|
2020
Q1 | $280K | Sell |
10,400
-2,000
| -16% | -$59.7K | ﹤0.01% | 7458 |
|
|
2019
Q4 | $418K | Buy |
12,400
+3,400
| +38% | +$123K | ﹤0.01% | 7095 |
|
|
2019
Q3 | $337K | Sell |
9,000
-5,700
| -39% | -$217K | ﹤0.01% | 7388 |
|
|
2019
Q2 | $641K | Sell |
14,700
-3,300
| -18% | -$141K | ﹤0.01% | 6423 |
|
|
2019
Q1 | $768K | Buy |
+18,000
| New | +$806K | ﹤0.01% | 6061 |
|
|
2018
Q4 | – | Sell |
-18,000
| Closed | -$1.23M | – | 9093 |
|
|
2018
Q3 | $1.23M | Sell |
18,000
-15,100
| -46% | -$972K | ﹤0.01% | 5179 |
|
|
2018
Q2 | $1.9M | Buy |
33,100
+2,600
| +9% | +$137K | ﹤0.01% | 4200 |
|
|
2018
Q1 | $1.41M | Buy |
30,500
+24,400
| +400% | +$1.16M | ﹤0.01% | 4279 |
|
|
2017
Q4 | $282K | Sell |
6,100
-2,500
| -29% | -$115K | ﹤0.01% | 6560 |
|
|
2017
Q3 | $387K | Buy |
8,600
+1,900
| +28% | +$81.1K | ﹤0.01% | 5682 |
|
|
2017
Q2 | $263K | Buy |
+6,700
| New | +$253K | ﹤0.01% | 6121 |
|
|
2017
Q1 | – | Sell |
-8,500
| Closed | -$314K | – | 7424 |
|
|
2016
Q4 | $314K | Buy |
8,500
+1,600
| +23% | +$57.2K | ﹤0.01% | 5603 |
|
|
2016
Q3 | $239K | Sell |
6,900
-1,000
| -13% | -$35K | ﹤0.01% | 6042 |
|
|
2016
Q2 | $257K | Sell |
7,900
-1,500
| -16% | -$45.9K | ﹤0.01% | 5449 |
|
|
2016
Q1 | $270K | Sell |
9,400
-8,100
| -46% | -$216K | ﹤0.01% | 5231 |
|
|
2015
Q4 | $585K | Sell |
17,500
-800
| -4% | -$24.9K | ﹤0.01% | 4258 |
|
|
2015
Q3 | $520K | Buy |
18,300
+6,700
| +58% | +$234K | ﹤0.01% | 4761 |
|
|
2015
Q2 | $470K | Buy |
11,600
+6,900
| +147% | +$310K | ﹤0.01% | 5068 |
|
|
2015
Q1 | $231K | Buy |
4,700
+2,900
| +161% | +$134K | ﹤0.01% | 6007 |
|
|
2014
Q4 | $82K | Buy |
+1,800
| New | +$70.7K | ﹤0.01% | 6810 |
|
Other funds holding AVNS
AC
VCM
VPM
